| 001 | 138394 | ||
| 005 | 20240321220427.0 | ||
| 024 | 7 | _ | |a 10.1002/ana.24527 |2 doi |
| 024 | 7 | _ | |a pmid:26389967 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC4738170 |2 pmc |
| 024 | 7 | _ | |a 0364-5134 |2 ISSN |
| 024 | 7 | _ | |a 1531-8249 |2 ISSN |
| 024 | 7 | _ | |a altmetric:4538816 |2 altmetric |
| 037 | _ | _ | |a DZNE-2020-04716 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Lubbe, Steven J |b 0 |
| 245 | _ | _ | |a Is the MC1R variant p.R160W associated with Parkinson's? |
| 260 | _ | _ | |a Hoboken, NJ |c 2016 |b Wiley-Blackwell |
| 264 | _ | 1 | |3 online |2 Crossref |b Wiley |c 2015-12-12 |
| 264 | _ | 1 | |3 print |2 Crossref |b Wiley |c 2016-01-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1593429325_12122 |2 PUB:(DE-HGF) |x Letter |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 536 | _ | _ | |a 345 - Population Studies and Genetics (POF3-345) |0 G:(DE-HGF)POF3-345 |c POF3-345 |f POF III |x 0 |
| 542 | _ | _ | |i 2015-09-01 |2 Crossref |u http://doi.wiley.com/10.1002/tdm_license_1.1 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a Receptor, Melanocortin, Type 1 |2 NLM Chemicals |
| 650 | _ | 2 | |a Female |2 MeSH |
| 650 | _ | 2 | |a Genetic Predisposition to Disease: genetics |2 MeSH |
| 650 | _ | 2 | |a Genetic Variation: genetics |2 MeSH |
| 650 | _ | 2 | |a Humans |2 MeSH |
| 650 | _ | 2 | |a Male |2 MeSH |
| 650 | _ | 2 | |a Melanoma: genetics |2 MeSH |
| 650 | _ | 2 | |a Parkinson Disease: genetics |2 MeSH |
| 650 | _ | 2 | |a Receptor, Melanocortin, Type 1: genetics |2 MeSH |
| 700 | 1 | _ | |a Escott-Price, Valentina |b 1 |
| 700 | 1 | _ | |a Brice, Alexis |b 2 |
| 700 | 1 | _ | |a Gasser, Thomas |0 P:(DE-2719)2320009 |b 3 |u dzne |
| 700 | 1 | _ | |a Hardy, John |b 4 |
| 700 | 1 | _ | |a Heutink, Peter |0 P:(DE-2719)2810728 |b 5 |u dzne |
| 700 | 1 | _ | |a Sharma, Manu |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Wood, Nicholas W |b 7 |
| 700 | 1 | _ | |a Nalls, Mike |b 8 |
| 700 | 1 | _ | |a Singleton, Andrew B |b 9 |
| 700 | 1 | _ | |a Williams, Nigel M |b 10 |
| 700 | 1 | _ | |a Morris, Huw R |b 11 |
| 700 | 1 | _ | |a Consortium, International Parkinson's Disease Genomics |b 12 |
| 773 | 1 | 8 | |a 10.1002/ana.24527 |b : Wiley, 2015-12-12 |n 1 |p 159-161 |3 journal-article |2 Crossref |t Annals of Neurology |v 79 |y 2015 |x 0364-5134 |
| 773 | _ | _ | |a 10.1002/ana.24527 |g Vol. 79, no. 1, p. 159 - 161 |0 PERI:(DE-600)2037912-2 |n 1 |q 79:1<159 - 161 |p 159-161 |t Annals of neurology |v 79 |y 2015 |x 0364-5134 |
| 856 | 7 | _ | |2 Pubmed Central |u http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4738170 |
| 909 | C | O | |o oai:pub.dzne.de:138394 |p VDB |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 3 |6 P:(DE-2719)2320009 |
| 910 | 1 | _ | |a Deutsches Zentrum für Neurodegenerative Erkrankungen |0 I:(DE-588)1065079516 |k DZNE |b 5 |6 P:(DE-2719)2810728 |
| 913 | 1 | _ | |a DE-HGF |b Forschungsbereich Gesundheit |l Erkrankungen des Nervensystems |1 G:(DE-HGF)POF3-340 |0 G:(DE-HGF)POF3-345 |2 G:(DE-HGF)POF3-300 |v Population Studies and Genetics |x 0 |
| 914 | 1 | _ | |y 2016 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b ANN NEUROL : 2017 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b ANN NEUROL : 2017 |
| 920 | 1 | _ | |0 I:(DE-2719)1210000 |k AG Gasser 1 |l Parkinson Genetics |x 0 |
| 920 | 1 | _ | |0 I:(DE-2719)1210002 |k AG Heutink 1 |l Genome Biology of Neurodegenerative Diseases |x 1 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-2719)1210000 |
| 980 | _ | _ | |a I:(DE-2719)1210002 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1002/ijc.23396 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ijc.23396 |
| 999 | C | 5 | |a 10.1002/ana.24373 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/ana.24373 |
| 999 | C | 5 | |y 2014 |2 Crossref |o Dong 2014 |
| 999 | C | 5 | |a 10.1002/humu.20476 |9 -- missing cx lookup -- |2 Crossref |o 10.1002/humu.20476 |
| 999 | C | 5 | |a 10.1038/nature15393 |9 -- missing cx lookup -- |2 Crossref |o 10.1038/nature15393 |
| 999 | C | 5 | |a 10.1186/1471-2164-11-326 |9 -- missing cx lookup -- |2 Crossref |o 10.1186/1471-2164-11-326 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|